# Report: 1_OPC_AC_like_1 (run_1.md)

**Cell type:** glioblastoma cells
**Disease:** malignant glioblastoma
**Tissue:** brain

## Program Summaries
### CD44-mediated Invasive Adhesion
Coordinated regulation of cell-cell and cell-matrix adhesion through CD44 receptor interactions with hyaluronic acid and other extracellular matrix components. CD44 mediates formation of microtentacles and stabilizes migrating cell morphology during glioma invasion through orchestration of cytoskeletal dynamics and downstream signaling pathways.

**Predicted impacts:**
- Enhanced dynamic adhesion enabling rapid migration through matrix-rich brain parenchyma
- Switching between individual and collective migration modes
- Increased tumor cell invasiveness and reduced chemoresistance through CD44-mediated multidrug transporter activation
- Resistance to conventional therapies through CD44-dependent survival signaling

**Supporting genes:** CD44, ITGB4

**References:** [12], [20], [9]

**Biological processes:**
- CD44-hyaluronic acid binding and mechanotransduction: CD44
- Cytoskeletal linking and microtubule-actin dynamics: CD44, ITGB4
- Growth factor receptor crosstalk and Src family kinase activation: CD44, ITGB4

**Cellular components:**
- Microtentacle protrusions: CD44
- Focal adhesion complexes: CD44, ITGB4

**Reference notes:**
- Mechanism of CD44-mediated microtentacle formation in GBM adhesion and invasion
- CD44 dual activities in promoting invasion and proliferation via multiple signaling pathways in GBM
- CD44v maintenance of SLC7A11 protein stability affecting tumor formation

### Integrin-mediated Migration and EMT
ITGB4 integrin functions as a mechanosensor promoting tumor migration and invasion through epithelial-mesenchymal transition (EMT) programs, activated by engagement with extracellular ligands and coordinated with growth factor receptor signaling via focal adhesion kinase and phosphoinositide 3-kinase pathways.

**Predicted impacts:**
- Enhanced FAK-mediated signaling promoting migration and invasion capacity
- Coordinated activation of EMT programs enhancing mesenchymal phenotype
- Increased phosphorylation and activation of downstream AKT and ERK pathways
- Promotion of collective invasion through matrix-associated signaling

**Supporting genes:** ITGB4

**References:** [15], [18]

**Biological processes:**
- Integrin αβ4 ligand engagement and FAK phosphorylation: ITGB4
- PI3K/AKT and MAPK signaling activation: ITGB4
- EMT and stemness program activation: ITGB4

**Cellular components:**
- Hemidesmosomes and focal adhesion complexes: ITGB4

**Reference notes:**
- ITGB4 promotes HCC proliferation, invasion, and EMT via Slug-mediated mechanisms
- Comprehensive review of ITGB4 mechanisms in tumor migration and invasion across multiple cancer types

### N-cadherin-dependent Context-specific Migration
N-cadherin (CDH2) functions as a context-dependent regulator of glioma cell migration, promoting movement on neural cell surfaces while inhibiting migration through extracellular matrix. Intercellular homotypic N-cadherin interactions enable collective invasion through alternating engagement with different cellular environments.

**Predicted impacts:**
- Promotion of migration along white matter tracts and gray matter interfaces
- Facilitation of collective invasion with coordinated cell movement
- Dynamic switching between migration routes based on local environment
- Reduced individual cell migration capacity but enhanced coordinated advancement

**Supporting genes:** CDH18

**References:** [41]

**Biological processes:**
- Homotypic N-cadherin-mediated cell-cell adhesion: CDH18
- Neural cell-glioma heterotypic adhesion signaling: CDH18

**Cellular components:**
- Adherens junction assembly: CDH18

**Reference notes:**
- N-cadherin differentially regulates glioma migration based on environmental context

### Extracellular Matrix Remodeling
Active ECM remodeling via ADAMTS family proteases, collagen biosynthesis and deposition, and tenascin-C expression in glioblastoma creates a permissive microenvironment for tumor progression. ECM components serve as both structural scaffolds and bioactive signaling molecules regulating tumor cell behavior.

**Predicted impacts:**
- Enhanced tumor cell migration through enzymatic matrix degradation
- Creation of physical scaffolds supporting collective invasion
- Generation of bioactive ECM fragments promoting tumor cell signaling
- Promotion of vascular invasion and angiogenesis through TNC-mediated effects

**Supporting genes:** ADAMTS5, COL20A1, TNR

**References:** [26], [39], [42], [49]

**Biological processes:**
- Matrix metalloproteinase and ADAMTS-mediated proteolysis: ADAMTS5
- Collagen deposition and crosslinking: COL20A1
- Tenascin-C and TNR glycoprotein expression: TNR

**Cellular components:**
- Basement membrane composition: COL20A1
- Perivascular ECM niche: TNR, COL20A1

**Reference notes:**
- Tenascin-C is overexpressed in GBM and serves as therapeutic target for CAR T cells
- Collagen profiles predict genetic features and patient prognosis across tumor types
- Comprehensive review of collagen and ECM receptors in driving glioma progression
- Systematic review of ECM role in shaping glioblastoma tumor development

### Metabolic Reprogramming and Redox Homeostasis
Coordinated upregulation of oxidative phosphorylation (via PPARGC1A), cystine-glutamate exchange (via SLC7A11), and DNA repair mechanisms (via EEPD1) enables glioblastoma cells to manage replication stress, maintain redox balance, and sustain proliferation under nutrient-limited conditions.

**Predicted impacts:**
- Enhanced ATP production supporting high energy demands of proliferation
- Maintenance of reducing potential enabling rapid biosynthesis
- Protection from ferroptosis and oxidative stress-induced apoptosis
- Sustained proliferation under nutrient-limited tumor microenvironment
- Increased resistance to oxidative therapy-induced damage

**Supporting genes:** PPARGC1A, SLC7A11, EEPD1

**References:** [19], [20], [8]

**Biological processes:**
- PPARGC1A-driven mitochondrial biogenesis and OXPHOS: PPARGC1A
- SLC7A11-mediated cystine uptake and glutathione synthesis: SLC7A11
- EEPD1-mediated replication fork stability: EEPD1

**Cellular components:**
- Mitochondrial cristae and electron transport chain: PPARGC1A
- Plasma membrane cystine/glutamate antiporter: SLC7A11

**Reference notes:**
- PGC-1α drives SCNC progression and metabolic reprogramming via OXPHOS
- Comprehensive review of SLC7A11 in cancer metabolism and ferroptosis resistance
- EEPD1 dysregulation correlates with poor prognosis and affects immune infiltration

### Immune Evasion and Checkpoint Regulation
Coordinated suppression of MHC class I antigen presentation via altered NLRC5 signaling and expression of immunomodulatory molecules enables glioblastoma cells to escape T cell recognition. Extracellular vesicle-mediated transfer of Arc protein facilitates intercellular communication within tumor cell networks and immune evasion.

**Predicted impacts:**
- Reduced MHC class I expression on tumor cell surface limiting CD8+ T cell recognition
- Enhanced intercellular communication through EV-mediated mRNA transfer
- Promotion of glioma cell heterogeneity and plasticity through Arc signaling
- Facilitation of adaptive immune evasion mechanisms

**Supporting genes:** NLRC5, ARC, CD44

**References:** [21], [24], [31]

**Biological processes:**
- NLRC5-dependent MHC class I transcriptional regulation: NLRC5
- Arc-mediated extracellular vesicle biogenesis and intercellular communication: ARC
- CD44-mediated immune cell suppression: CD44

**Cellular components:**
- MHC class I-peptide complex: NLRC5
- Extracellular vesicles and exosomes: ARC

**Reference notes:**
- NLRC5 is transcriptional regulator of MHC class I antigen presentation
- Arc protein involved in extracellular vesicle-mediated mRNA transfer between glioma cells
- NLRC5 functions beyond MHC I regulation in immune responses

### Ganglioside and Glycosylation-based Signaling
Expression of ganglioside synthesis enzymes (ST8SIA1, ST8SIA5) and glycosyltransferases (CHST8, XYLT1) in glioblastoma promotes tumor progression through enhanced cell surface glycosylation. GD3 ganglioside and related glycosphingolipids activate oncogenic signaling cascades and promote stemness, angiogenesis, and immune evasion.

**Predicted impacts:**
- Enhanced GD3 expression promoting glioma stemness and self-renewal capacity
- Activation of oncogenic RTK signaling through GD3-mediated receptor clustering
- Increased tumor angiogenesis through GD3-promoted VEGF release
- Enhanced immunosuppression through ganglioside-mediated T cell inhibition
- Altered cell adhesion and metastatic potential through modified cell surface glycosylation

**Supporting genes:** ST8SIA1, ST8SIA5, XYLT1, CHST8

**References:** [3], [43], [6]

**Biological processes:**
- ST8SIA-mediated sialic acid chain synthesis: ST8SIA1, ST8SIA5
- XYLT1-mediated xylose attachment for GAG biosynthesis: XYLT1
- CHST8-mediated carbohydrate sulfation: CHST8
- GD3-mediated RTK activation and MAP kinase signaling: ST8SIA1, ST8SIA5

**Cellular components:**
- Glycolipid-enriched microdomains (rafts): ST8SIA1, ST8SIA5
- Heparan sulfate and chondroitin sulfate GAG chains: XYLT1, CHST8

**Reference notes:**
- Comprehensive review of GD3 ganglioside as promising therapeutic target in glioma
- α-Xylosides inhibit GAG biosynthesis and glioma cell viability
- XYLT1 activates NF-κB signaling to promote cancer metastasis

### Neural-like Developmental Signaling
Coordinated expression of neuroligin/netrin receptor systems (LRRC4C, MDGA2, UNC5D) and guidance molecule receptors (RGMA, DAB1) in glioblastoma mimics developmental neural signaling pathways. These systems regulate glioma cell migration patterns, synaptic-like contacts, and interactions with host neural tissue.

**Predicted impacts:**
- Enhanced glioma cell migration through neural pathways along white matter tracts
- Formation of neuroglial synaptic-like contacts promoting tumor progression
- Escape from repulsive guidance cues enabling migration into neural tissue
- Exploitation of developmental neural wiring for dissemination

**Supporting genes:** LRRC4C, MDGA2, UNC5D, RGMA, DAB1

**References:** [25], [27], [44], [51]

**Biological processes:**
- MDGA2-neuroligin-2 inhibitory synapse regulation: MDGA2
- LRRC4C-mediated synapse formation and plasticity: LRRC4C
- UNC5D/FLRT-mediated repulsive guidance and apoptosis: UNC5D
- RGMA-neogenin repulsive guidance signaling: RGMA
- DAB1-mediated reelin signaling and neuronal positioning: DAB1

**Cellular components:**
- Synaptic adhesion complexes: MDGA2, LRRC4C
- Growth cone guidance structures: UNC5D, RGMA

**Reference notes:**
- RGMA is elevated in GBM and associated with poor prognosis through NEO1 interaction
- LRRC4 is tumor suppressor in gliomas and regulates synaptic plasticity
- MDGA interactions with neuroligin-2 regulate inhibitory synapse formation
- UNC5 receptors regulate migration and survival through FLRT interactions

### GFAP Isoform-dependent Malignancy
Dynamic regulation of GFAP alternative splicing in glioblastoma, with increased GFAPδ expression and elevated GFAPδ/GFAPα ratio marking malignant transformation. GFAPδ-dependent signaling promotes invasiveness through MAPK pathway modulation and extracellular matrix interaction changes.

**Predicted impacts:**
- Enhanced tumor invasiveness through DUSP4-mediated MAPK modulation
- Increased risk for early recurrence and poor prognosis
- Altered ECM engagement promoting migration through brain parenchyma
- Enhanced malignant gene expression programs in high-grade tumors

**Supporting genes:** GFAP

**References:** [13], [16]

**Biological processes:**
- GFAP alternative splicing and isoform switching: GFAP
- DUSP4/MAPK phosphatase activation by GFAPδ: GFAP
- ECM interaction pathway modulation: GFAP

**Cellular components:**
- Intermediate filament cytoskeleton: GFAP

**Reference notes:**
- GFAPδ is promising biomarker and therapeutic target in glioblastoma
- Importance of GFAP isoform-specific analyses in astrocytoma malignancy assessment

### Long Non-Coding RNA Regulatory Networks
Dysregulated expression of multiple long non-coding RNAs (lncRNAs) in glioblastoma orchestrates tumor progression through competing endogenous RNA (ceRNA) networks, regulation of mRNA stability, and modulation of chromatin structure. lncRNAs serve as scaffolds for transcriptional regulation and affect immune cell infiltration.

**Predicted impacts:**
- Dysregulated expression of tumor suppressor and oncogene networks
- Altered immune cell recruitment and infiltration patterns
- Enhanced tumor cell proliferation and survival through miRNA depletion
- Modulation of cell cycle checkpoints and apoptosis evasion
- Increased epithelial-mesenchymal transition and stemness programs

**Supporting genes:** LINC01727, AC117464.1, LINC02125, LINC02246, LINC01776, LINC01117, LINC02328, AL353138.1, AL356737.2, AL159156.1, AC077690.1, AC019068.1, AC013265.1, AC233296.1, AC124254.2, AC007344.1, MIR3681HG, LUCAT1

**References:** [11], [37], [4]

**Biological processes:**
- ceRNA-mediated miRNA sponging and mRNA regulation: LINC01727, AC117464.1, LINC02125, LINC02246, LINC01776, LINC01117, LINC02328, AL353138.1, AL356737.2, AL159156.1, AC077690.1, AC019068.1, AC013265.1, AC233296.1, AC124254.2, AC007344.1, MIR3681HG, LUCAT1
- lncRNA scaffolding of transcriptional complexes: LINC01727, AC117464.1, LINC02125, LINC02246, LINC01776, LINC01117, LINC02328, AL353138.1, AL356737.2, AL159156.1, AC077690.1, AC019068.1, AC013265.1, AC233296.1, AC124254.2, AC007344.1, MIR3681HG, LUCAT1
- lncRNA-mediated immune infiltration and microenvironment remodeling: LINC01727, AC117464.1, LINC02125, LINC02246, LINC01776, LINC01117, LINC02328, AL353138.1, AL356737.2, AL159156.1, AC077690.1, AC019068.1, AC013265.1, AC233296.1, AC124254.2, AC007344.1, MIR3681HG, LUCAT1

**Cellular components:**
- lncRNA-miRNA complexes: LINC01727, AC117464.1, LINC02125, LINC02246, LINC01776, LINC01117, LINC02328, AL353138.1, AL356737.2, AL159156.1, AC077690.1, AC019068.1, AC013265.1, AC233296.1, AC124254.2, AC007344.1, MIR3681HG, LUCAT1

**Reference notes:**
- Comprehensive review of lncRNA functions and unique features in cancer
- lncRNAs regulate immune cell infiltration and tumor microenvironment in HNSCC
- lncRNAs regulate EMT, cell cycle, stemness, and apoptosis in esophageal squamous cell carcinoma

### PI3K/AKT Signaling Modulation
INPP4B phosphatase regulates PI3K/AKT signaling by converting PI(3,4)P2 to PI(3)P, with context-dependent effects on tumor progression. In PIK3CA-mutant ER+ breast cancers, INPP4B promotes Wnt/β-catenin signaling through late endosome formation, while in triple-negative breast cancers, INPP4B loss enhances AKT activation.

**Predicted impacts:**
- Context-dependent modulation of AKT signaling strength
- Enhanced Wnt/β-catenin pathway activation in specific tumor contexts
- Altered response to PI3K inhibitor therapies
- Differential tumor suppressor versus oncogenic activities in different cancer subtypes

**Supporting genes:** INPP4B

**References:** [33], [36]

**Biological processes:**
- INPP4B-mediated phosphoinositide conversion on late endosomes: INPP4B
- PI3K/AKT pathway regulation: INPP4B
- Wnt/β-catenin crosstalk with PI3K signaling: INPP4B

**Cellular components:**
- Late endosome signaling hub: INPP4B
- ESCRT complex assembly: INPP4B

**Reference notes:**
- INPP4B facilitates PI3Kα-dependent late endosome formation and Wnt signaling crosstalk
- INPP4B regulates PI3K/AKT signaling in ER-positive breast cancer

### Calcium-dependent Cell Adhesion
CDH18 and DCHS2 encode calcium-dependent cadherins mediating neural cell adhesion and affecting tumor progression through modulation of adhesive properties and immune cell interactions. CDH18 associates with macrophages in tumor microenvironment and affects immunotherapy resistance.

**Predicted impacts:**
- Altered glioma cell adhesion and invasiveness based on calcium availability
- Modulation of immune cell-tumor cell interactions
- Effects on chemotherapy resistance through macrophage engagement
- Influence on tumor microenvironment composition and function

**Supporting genes:** CDH18, DCHS2

**References:** [38]

**Biological processes:**
- Calcium-dependent CDH18 adhesion: CDH18
- CDH18-mediated immune cell interactions: CDH18
- DCHS2 cadherin-mediated cell adhesion: DCHS2

**Cellular components:**
- Adherens junctions: CDH18, DCHS2

**Reference notes:**
- CDH18 is novel promising biomarker in UCEC with roles in tumor progression and immune modulation

### Transcriptional Co-regulator Activity
MN1 meningioma-1 acts as essential co-factor in MLL fusion leukemias maintaining active transcription of HOXA cluster genes and their targets. MN1 high expression marks poor prognosis and its loss impairs leukemia proliferation, suggesting potential broader roles in glioblastoma transcriptional control.

**Predicted impacts:**
- Maintenance of proliferative and survival gene expression programs
- Resistance to differentiation and apoptosis cues
- Altered chromatin architecture and transcriptional memory
- Poor prognosis association in affected tumors

**Supporting genes:** MN1

**References:** [45]

**Biological processes:**
- MN1-mediated transcriptional maintenance of HOXA cluster: MN1
- MN1-dependent regulation of anti-apoptotic factors: MN1

**Cellular components:**
- Transcriptional co-regulator complexes: MN1

**Reference notes:**
- MN1 is indispensable for MLL fusion leukemia and serves as therapeutic target

### Heparan Sulfate Proteoglycan Signaling
GPC5 glypican-5 heparan sulfate proteoglycan functions as tumor suppressor in glioblastoma and other cancers by promoting Sonic Hedgehog co-receptor activity and antagonizing Wnt/β-catenin signaling. Reduced GPC5 expression correlates with increased proliferation and poor prognosis.

**Predicted impacts:**
- Reduced proliferation through Wnt/β-catenin pathway antagonism
- Decreased cell migration and invasiveness
- Impaired tumor growth in xenograft models
- Enhanced differentiation and reduced stemness

**Supporting genes:** GPC5

**References:** [50], [57]

**Biological processes:**
- GPC5-mediated Sonic Hedgehog co-receptor function: GPC5
- GPC5-dependent Wnt/β-catenin pathway antagonism: GPC5

**Cellular components:**
- Primary cilium localization: GPC5
- Cell surface heparan sulfate chains: GPC5

**Reference notes:**
- GPC5 is glypican with pivotal role in developmental processes and tumor suppression
- GPC5 and glypican family members regulate cell proliferation and growth

### Histamine Receptor Signaling
HRH1 histamine H1-receptor promotes tumorigenesis through ERK/EGR1 signaling axis while HRH2 H2-receptor antagonizes these effects. The HRH2/HRH1 expression ratio predicts patient survival, suggesting bimodal histamine signaling roles in glioblastoma and other cancers.

**Predicted impacts:**
- Enhanced tumor cell proliferation and survival through H1R-mediated ERK signaling
- Increased chemokine-mediated immune cell recruitment and tumor-promoting inflammation
- Protective effects through H2R-mediated ERK suppression
- Bimodal regulation of tumor growth based on HRH2/HRH1 expression ratio

**Supporting genes:** HRH1

**References:** [32]

**Biological processes:**
- HRH1-mediated ERK activation and proliferation: HRH1
- HRH2-mediated ERK suppression: HRH1
- Histamine-mediated chemokine expression: HRH1

**Cellular components:**
- G-protein coupled receptors: HRH1

**Reference notes:**
- Distinct roles of histamine H1 and H2 receptor signaling in colorectal cancer

## References
- [11] Notes: lncRNAs regulate EMT, cell cycle, stemness, and apoptosis in esophageal squamous cell carcinoma
- [12] Notes: CD44 dual activities in promoting invasion and proliferation via multiple signaling pathways in GBM
- [13] Notes: GFAPδ is promising biomarker and therapeutic target in glioblastoma
- [15] Notes: ITGB4 promotes HCC proliferation, invasion, and EMT via Slug-mediated mechanisms
- [16] Notes: Importance of GFAP isoform-specific analyses in astrocytoma malignancy assessment
- [18] Notes: Comprehensive review of ITGB4 mechanisms in tumor migration and invasion across multiple cancer types
- [19] Notes: PGC-1α drives SCNC progression and metabolic reprogramming via OXPHOS
- [20] Notes: CD44v maintenance of SLC7A11 protein stability affecting tumor formation | Comprehensive review of SLC7A11 in cancer metabolism and ferroptosis resistance
- [21] Notes: NLRC5 is transcriptional regulator of MHC class I antigen presentation
- [24] Notes: NLRC5 functions beyond MHC I regulation in immune responses
- [25] Notes: UNC5 receptors regulate migration and survival through FLRT interactions
- [26] Notes: Tenascin-C is overexpressed in GBM and serves as therapeutic target for CAR T cells
- [27] Notes: MDGA interactions with neuroligin-2 regulate inhibitory synapse formation
- [3] Notes: XYLT1 activates NF-κB signaling to promote cancer metastasis
- [31] Notes: Arc protein involved in extracellular vesicle-mediated mRNA transfer between glioma cells
- [32] Notes: Distinct roles of histamine H1 and H2 receptor signaling in colorectal cancer
- [33] Notes: INPP4B facilitates PI3Kα-dependent late endosome formation and Wnt signaling crosstalk
- [36] Notes: INPP4B regulates PI3K/AKT signaling in ER-positive breast cancer
- [37] Notes: Comprehensive review of lncRNA functions and unique features in cancer
- [38] Notes: CDH18 is novel promising biomarker in UCEC with roles in tumor progression and immune modulation
- [39] Notes: Collagen profiles predict genetic features and patient prognosis across tumor types
- [4] Notes: lncRNAs regulate immune cell infiltration and tumor microenvironment in HNSCC
- [41] Notes: N-cadherin differentially regulates glioma migration based on environmental context
- [42] Notes: Comprehensive review of collagen and ECM receptors in driving glioma progression
- [43] Notes: Comprehensive review of GD3 ganglioside as promising therapeutic target in glioma
- [44] Notes: RGMA is elevated in GBM and associated with poor prognosis through NEO1 interaction
- [45] Notes: MN1 is indispensable for MLL fusion leukemia and serves as therapeutic target
- [49] Notes: Systematic review of ECM role in shaping glioblastoma tumor development
- [50] Notes: GPC5 and glypican family members regulate cell proliferation and growth
- [51] Notes: LRRC4 is tumor suppressor in gliomas and regulates synaptic plasticity
- [57] Notes: GPC5 is glypican with pivotal role in developmental processes and tumor suppression
- [6] Notes: α-Xylosides inhibit GAG biosynthesis and glioma cell viability
- [8] Notes: EEPD1 dysregulation correlates with poor prognosis and affects immune infiltration
- [9] Notes: Mechanism of CD44-mediated microtentacle formation in GBM adhesion and invasion
